Nuclear Medicine Our Product Portfolio

Discover our portfolio of radiodiagnostics and therapeutic — designed to support better outcomes for patients worldwide.

01
Supporting the diagnosis and management of cardiovascular diseases.
02
Advancing nuclear medicine solutions for endocrine and metabolic disorders.
03
Supporting the evaluation of gastrointestinal function and disease through precision imaging.
04
Providing nuclear medicine solutions for blood disorders and related cancers.
05
Helping detect and monitor infection and inflammatory disease with precision imaging.
06
Supporting liver and spleen imaging with specialised nuclear medicine solutions.
07
Advancing lymphatic imaging solutions for disease staging and treatment planning.
08
Enhancing the detection and monitoring of bone and joint conditions.
09
Supporting renal imaging and kidney function assessment through nuclear medicine.
10
Advancing brain imaging solutions for neurological disorders and diseases.
11
Delivering precision nuclear medicine solutions for cancer diagnosis and treatment.
12
Supporting lung imaging and respiratory assessment with advanced nuclear medicine solutions.
13
Providing reliable radionuclide generator technologies for diagnostic isotope production.
14
Supporting the diagnosis and treatment of rare diseases through specialised nuclear medicine solutions.
15
Supporting the evaluation of inflammatory and autoimmune musculoskeletal disorders.
16
Providing nuclear medicine solutions for the diagnosis and management of urological conditions.

Selected

Disease Area

Cardiology
Endocrinology
Gastroenterology
Hematology
Infectious Diseases
Liver & Spleen
Lymphology
Musculoskeletal
Nephrology
Neurology
Oncology
Pulmonology
Radionuclide Generators
Rare Diseases
Rheumatology
Urology

Product Type

Therapeutic
PET
SPECT
Active Ingredient
Medical Device

Manufacturing Site

Maryland Heights
Petten
Saclay
Gebze

Market

All products A-Z

Technescan MAG3™

(Kit for the preparation of technetium Tc99m mertiatide injection)

Active ingredient

Betiatide

Disease area

Nephrology, Urology

Available in
, 

Technescan MAG3™ in Australia

Product information
, 

Technescan MAG3™ in United States

Product information

Technescan™ DTPA

TechneScan DTPA 20.8 mg kit for radiopharmaceutical preparation

Active ingredient

Pentetic acid

Disease area

Nephrology, Neurology, Pulmonology, Urology

Available in
, 

Technescan™ DTPA in Austria

Product information
, 

Technescan™ DTPA in Belgium

Product information
, 

Technescan™ DTPA in Colombia

Product information
, 

Technescan™ DTPA in Czech Republic

Product information
, 

Technescan™ DTPA in Denmark

Product information
, 

Technescan™ DTPA in Finland

Product information
, 

Technescan™ DTPA in France

Product information
, 

Technescan™ DTPA in Germany

Product information
, 

Technescan™ DTPA in Greece

Product information
, 

Technescan™ DTPA in Hong Kong

Product information
, 

Technescan™ DTPA in Hungary

Product information
, 

Technescan™ DTPA in Ireland

Product information
, 

Technescan™ DTPA in Italy

Product information
, 

Technescan™ DTPA in Mexico

Product information
, 

Technescan™ DTPA in Moldova

Product information
, 

Technescan™ DTPA in Netherlands

Product information
, 

Technescan™ DTPA in Norway

Product information
, 

Technescan™ DTPA in Peru

Product information
, 

Technescan™ DTPA in Portugal

Product information
, 

Technescan™ DTPA in Republic of Korea

Product information
, 

Technescan™ DTPA in Romania

Product information
, 

Technescan™ DTPA in Singapore

Product information
, 

Technescan™ DTPA in Slovakia

Product information
, 

Technescan™ DTPA in Spain

Product information
, 

Technescan™ DTPA in Sweden

Product information
, 

Technescan™ DTPA in Switzerland

Product information
, 

Technescan™ DTPA in Turkey

Product information

Technescan™ DTPA in United Kingdom

Product information

Technescan™ MAG3

Technescan MAG3, 1 mg kit for radiopharmaceutical preparation

Active ingredient

Mertiatide

Disease area

Nephrology, Urology

Available in
, 

Technescan™ MAG3 in Austria

Product information
, 

Technescan™ MAG3 in Belgium

Product information
, 

Technescan™ MAG3 in Colombia

Product information
, 

Technescan™ MAG3 in Czech Republic

Product information
, 

Technescan™ MAG3 in Denmark

Product information
, 

Technescan™ MAG3 in Finland

Product information
, 

Technescan™ MAG3 in France

Product information
, 

Technescan™ MAG3 in Germany

Product information
, 

Technescan™ MAG3 in Greece

Product information
, 

Technescan™ MAG3 in Hungary

Product information
, 

Technescan™ MAG3 in Ireland

Product information
, 

Technescan™ MAG3 in Italy

Product information
, 

Technescan™ MAG3 in Malaysia

Product information
, 

Technescan™ MAG3 in Mexico

Product information
, 

Technescan™ MAG3 in Netherlands

Product information
, 

Technescan™ MAG3 in Norway

Product information
, 

Technescan™ MAG3 in Peru

Product information
, 

Technescan™ MAG3 in Portugal

Product information
, 

Technescan™ MAG3 in Republic of Korea

Product information
, 

Technescan™ MAG3 in Slovakia

Product information
, 

Technescan™ MAG3 in Spain

Product information
, 

Technescan™ MAG3 in Sweden

Product information
, 

Technescan™ MAG3 in Switzerland

Product information
, 

Technescan™ MAG3 in Turkey

Product information

Technescan™ MAG3 in United Kingdom

Product information

Ultra-Technekow™ V4

(technetium Tc 99m generator)

Active ingredient

Sodium molybdate (Mo-99)/sodium pertechnetate (Tc-99m)

Disease area

Endocrinology, Radionuclide Generators, Urology